We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$7.42B
AUM Growth
+$1.24B
(+20%)
Cap. Flow
+$985M
Cap. Flow
% of AUM
13.27%
Top 10 Holdings %
Top 10 Hldgs %
10.68%
Holding
3,037
New
854
Increased
791
Reduced
777
Closed
600
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$49.3M |
| 2 |
Intuit
INTU
|
+$48.7M |
| 3 |
Costco
COST
|
+$47.9M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$47.4M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$45.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$41M |
| 2 |
Dollar General
DG
|
+$39M |
| 3 |
Biogen
BIIB
|
+$36.8M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$29.8M |
| 5 |
Waste Management
WM
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Consumer Discretionary | 16.12% |
| 3 | Healthcare | 11.21% |
| 4 | Financials | 10.17% |
| 5 | Industrials | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WMGI
1301
DELISTED
Wright Medical Group Inc
WMGI
| $596K | 0.01% |
+19,510
| New | +$589K |
|
1302
CALL
NVIDIA
NVDA
$5.01T
| $595K | 0.01% |
+44,000
| New | +$512K |
|
1303
Whirlpool
WHR
$2.42B
| $595K | 0.01% |
+3,233
| New | +$537K |
|
1304
Ares Capital
ARCC
$13.5B
| $594K | 0.01% |
+42,566
| New | +$606K |
|
1305
AdvanSix
ASIX
$567M
| $594K | 0.01% |
46,143
+6,365
| +16% | +$79.5K |
|
1306
Commercial Vehicle Group
CVGI
$157M
| $592K | 0.01% |
+90,666
| New | +$350K |
|
|
SGMO
1307
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $589K | 0.01% |
+62,380
| New | +$675K |
|
1308
Hecla Mining
HL
$10.2B
| $588K | 0.01% |
+115,704
| New | +$612K |
|
|
NSTG
1309
DELISTED
NanoString Technologies, Inc.
NSTG
| $588K | 0.01% |
+13,149
| New | +$511K |
|
1310
Integra LifeSciences
IART
$1.54B
| $587K | 0.01% |
12,441
+2,542
| +26% | +$121K |
|
|
LTC
1311
LTC Properties
LTC
$2.16B
| $586K | 0.01% |
+16,816
| New | +$620K |
|
1312
Oppenheimer Holdings
OPY
$1.17B
| $586K | 0.01% |
26,257
+8,148
| +45% | +$189K |
|
1313
BridgeBio Pharma
BBIO
$16.5B
| $585K | 0.01% |
15,595
-1,741
| -10% | -$54.8K |
|
1314
Westamerica Bancorp
WABC
$1.39B
| $585K | 0.01% |
10,770
-1,600
| -13% | -$93.6K |
|
|
CURO
1315
DELISTED
CURO Group Holdings Corp.
CURO
| $585K | 0.01% |
+83,038
| New | +$632K |
|
1316
Albertsons Companies
ACI
$5.4B
| $583K | 0.01% |
42,094
-557,906
| -93% | -$8.14M |
|
1317
IDT Corp
IDT
$1.6B
| $583K | 0.01% |
88,562
+32,655
| +58% | +$215K |
|
|
AIOT
1318
PowerFleet Inc
AIOT
$500M
| $583K | 0.01% |
103,616
+61,187
| +144% | +$324K |
|
1319
Viking Therapeutics
VKTX
$4.04B
| $580K | 0.01% |
+99,684
| New | +$686K |
|
|
TAST
1320
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $580K | 0.01% |
89,976
-29,275
| -25% | -$181K |
|
|
SRGA
1321
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $580K | 0.01% |
10,690
+9,193
| +614% | +$703K |
|
1322
Codexis
CDXS
$135M
| $579K | 0.01% |
49,294
+24,814
| +101% | +$309K |
|
1323
Morningstar
MORN
$6.56B
| $579K | 0.01% |
+3,603
| New | +$569K |
|
1324
Cabaletta Bio
CABA
$439M
| $578K | 0.01% |
53,299
-1,254
| -2% | -$14.4K |
|
1325
Ebang International Holdings
EBON
$12.7M
| $578K | 0.01% |
+1,848
| New | +$342K |
|
Similar funds
Squarepoint's Q3 2020 Portfolio in Review
As of Q3 2020, Squarepoint held 3,037 positions worth $7.42B, up 20% from $6.18B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $985M of net new capital in Q3 2020, opening 854 new positions and adding to 791 existing holdings. Its largest new stake was Salesforce: 186,017 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $41M trimmed.
- Squarepoint's largest Q3 2020 buy was Salesforce: 186,017 shares worth $46.8M.
- Squarepoint added most to Visa in Q3 2020, an estimated $49.3M increase.
- Squarepoint's biggest Q3 2020 reduction was Pfizer, cutting an estimated $41M.
- Squarepoint fully exited Biogen in Q3 2020, selling an estimated $36.8M.
- Squarepoint's ten largest holdings make up 11% of its $7.42B portfolio in Q3 2020.
- Squarepoint opened 854 new positions and closed 600 in Q3 2020.
- Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.42B.
Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.